New award for escitalopram oxalate tablets with exelan. Period of performance is MAR 17, 2024 to MAR 16, 2025 with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79724D0014
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505-- Escitalopram Tablets (VA-24-00002863) Pre-Solicitation · 36E79723R0025 · Posted Aug 3, 2023
- Last date to order 88% complete
- IDV ceiling
- $48,442,917.75
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Exelan Pharmaceuticals Inc. for Escitalopram Oxalate tablets on March 17, 2024, with a ceiling of $48,442,917.75 and no set-aside designation.
The contract covers supply of Escitalopram Oxalate tablets in three strengths (5 mg, 10 mg, and 20 mg) distributed through VA and DOD pharmaceutical prime vendor programs, with performance at Exelan's Boca Raton, Florida manufacturing and distribution facility and other designated federal delivery locations as specified by contracting agencies. The period of performance runs from March 17, 2024 to March 16, 2025, with four one-year options extending potential performance through March 16, 2029. The originating solicitation, posted August 3, 2023 with an August 14, 2023 due date, required assurance of uninterrupted drug supply across the VA, DOD, Bureau of Prisons, and Indian Health Service under the VA National Acquisition Center procurement framework. A modification issued in April 2026 incorporated Executive Order 14398 Section 5 and FAR clause 52.222-90, addressing discrimination requirements for federal contractors.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79724D0014?
36E79724D0014 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on March 17, 2024.
How much is contract 36E79724D0014 worth?
36E79724D0014's own ceiling is $48,442,918.
Who can order from contract 36E79724D0014?
36E79724D0014 is a single award indefinite delivery contract.
Was contract 36E79724D0014 competed?
The extent of competition for 36E79724D0014 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV